LEO Pharma Initiates Phase III Clinical Trial for Delgocitinib in China
Denmark-based LEO Pharma A/S has announced the commencement of a China Phase III clinical study...
Beijing Insurance Bureau Launches Pilot to Boost Access to NRDL Drugs
The Beijing Municipal Medical Insurance Bureau has announced the initiation of pilot work aimed at...
Beijing-Tianjin-Hebei Region Initiates Drug VBP with 37 Medicines, Including Biologics
The Beijing Municipal Medical Insurance Bureau has issued a notification to commence the drug volume-based...
Regeneron Pharmaceuticals Acquires Decibel Therapeutics to Advance Hearing Loss Treatments
Regeneron Pharmaceuticals (NASDAQ: REGN) has completed the acquisition of Decibel Therapeutics, a developer of gene...
Novo Nordisk Partners with Valo Health to Develop Cardiometabolic Disease Therapies
Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has announced a strategic partnership with US company...
Coherus Biosciences Awaits FDA Decision on Toripalimab with Year-End Approval Forecast
Coherus Biosciences Inc., (NASDAQ: CHRS), a US-based biotechnology company, has provided an update on the...
Cutia Therapeutics Files for Market Approval of CU-10201 with NMPA for Acne Treatment
Cutia Therapeutics (HKG: 2487), a developer focused on dermatology therapies, has announced the submission of...
United Laboratories Receives FDA Approval for Clinical Study of UBT251 for Obesity Treatment
United Laboratories International Holdings Ltd (HKG: 3933), a Hong Kong-based pharmaceutical company, has announced that...
BioTroy Therapeutics Receives US FDA IND Approval for Anti-Tumor Drug BT02
BioTroy Therapeutics, a Shanghai-based developer of cancer immunotherapies, has announced the receipt of Investigational New...
Sichuan Kelun-Biotech’s KL-A167 and SKB264 Gain Tacit Clinical Trial Approval in China
The Center for Drug Evaluation (CDE) website has indicated that Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd...
Sino Biopharmaceutical Reports H1 2023 Revenue Growth, Focus on Innovative Drugs
Sino Biopharmaceutical Ltd (HKG: 1177), a leading China-based biotech company, has released its financial report...
Suzhou Novoprotein and Shanghai Model Organisms Center Ink Global Partnership
Suzhou Novoprotein Scientific Co., Ltd, (SHA: 688137) a leading provider of protein technology and application...
Sihuan Pharmaceutical Reports H1 2023 Revenue Dip Amid R&D Focus
Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has released its financial report for the first...
CIRC Unveils FuZhi 1.0 Smart Nuclear Medicine System at Chinese Medical Association Meeting
China Isotope & Radiation Corporation (CIRC; HKG: 1763) has announced the launch of its innovative...
Hunchun Port Designated as Medical Materials Import Port by NMPA and GAC
The National Medical Products Administration (NMPA) and the General Administration of Customs have jointly released...
Baxter Appoints Wu Xin as China General Manager Amid Spin-Off of Kidney Care Business
Baxter (NYSE: BAX), a leading provider of healthcare products, has announced the appointment of Wu...
China Grand Pharmaceutical Reports H1 2023 Revenues and Pipeline Progress
China Grand Pharmaceutical and Healthcare Holdings Ltd (HKG: 0512; CGP) has released its financial report...
EC Approves AbbVie’s Tepkinly for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
The European Commission (EC) has granted marketing approval to AbbVie (NYSE: ABBV) for its bispecific...
Sanofi’s Altuviiio Receives Marketing Approval from Japan’s MHLW for Hemophilia A Treatment
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced that it has received marketing approval from...
Lepu ScienTech Reports 33% Revenue Growth in 2023 Interim Report
Lepu ScienTech Medical Technology (Shanghai) Co., Ltd, (HKG: 2291) a China-based medical technology company, has...